Matthew A Brown

Chief Scientific Officer

NHS England

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Matthew A Brown is the Chief Scientific Officer at Genomics England in the UK. His research focuses on the global epidemiology of spondyloarthritis, medical guidelines for rare conditions, and the role of genetic factors in rheumatic diseases. He has published extensively on topics including T cell responses in inflammatory conditions and the impact of polygenic risk scores on patient outcomes.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Collaborators (6)

Muhammad Khan

Professor Emeritus of Medicine

Case Western Reserve University School of Medicine

UNITED STATES

View details

Bjorn Winkens

University of Maastricht

NETHERLANDS

View details

Floris van Gaalen

Leiden University Medical Center

NETHERLANDS

View details

Sjef van der Linden

NETHERLANDS

View details

Martin Rudwaleit

Head

Bielefeld University

GERMANY

View details

Frederick Kaplan

Isaac & Rose Nassau Professor of Orthopaedic Molecular Medicine

University of Pennsylvania

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Matthew A Brown

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Global epidemiology of spondyloarthritis

Medical Guidelines for Fibrodysplasia Ossificans Progressiva

Further Evidence That Chondrocalcinosis 1 (CCAL1) is a Confirmed Mendelian Phenotype With a Known Molecular Basis

The Rare Therapies Launchpad: a pilot program for individualized medicines in the UK

Antigen-driven T cell responses in rheumatic diseases: insights from T cell receptor repertoire studies

Associations of sociodemographic, clinical factors and HLA-B alleles with enthesitis and peripheral arthritis in patients with ankylosing spondylitis

Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trials

Polygenic risk scores

HLA-B27, axial spondyloarthritis and survival

T cell Repertoire Profiling and the Mechanism by which HLA-B27 Causes Ankylosing Spondylitis

Collaborators (6)

Muhammad Khan

Bjorn Winkens

Floris van Gaalen

Sjef van der Linden

Martin Rudwaleit

Frederick Kaplan

Make your next move.